Notch in the kidney: Development and disease

Journal of Pathology

Volumn 226, Issue 2, 2012, Pages 394-403

  Sirin, Yasemin ^a   Susztak, Katalin ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

chronic kidney disease; development; kidney fibrosis; Notch signalling; regeneration; renal cell cancer; repair

Indexed keywords

ADAM PROTEIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; JAGGED1; NOTCH RECEPTOR; NOTCH2 RECEPTOR; WNT9B PROTEIN;

ACUTE KIDNEY FAILURE; ALAGILLE SYNDROME; APOPTOSIS; CELL COMMUNICATION; CELL NUCLEUS; CELL PROLIFERATION; CHRONIC KIDNEY DISEASE; EMBRYONIC STRUCTURES; ENDOCYTOSIS; EPITHELIAL MESENCHYMAL TRANSITION; GENE MUTATION; GLOMERULOPATHY; HENLE LOOP; HUMAN; KIDNEY DEVELOPMENT; KIDNEY DISEASE; KIDNEY DISTAL TUBULE; KIDNEY FIBROSIS; LIVER CANCER; MOLECULAR INTERACTION; NONHUMAN; PODOCYTE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN INDUCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TISSUE REGENERATION; TISSUE REPAIR; URETER; URETER BUD;

ANIMALS; CARCINOMA, RENAL CELL; CELL COMMUNICATION; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FIBROSIS; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY NEOPLASMS; MUTATION; RECEPTORS, NOTCH; REGENERATION;

EID: 82755160861     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2967     Document Type: Review

References (106)

1. Artavanis-Tsakonas S, Rand MD, Lake RJ,. Notch signaling: cell fate control and signal integration in development. Science (New York) 1999; 284: 770-776. (Pubitemid 29291335)
2. Sharma S, Sirin Y, Susztak K,. The story of Notch and chronic kidney disease. Curr Opin Nephrol Hypertens 2010; 20: 56-61.
3. Kopan R, Ilagan MX,. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 2009; 137: 216-233.
4. Ilagan MX, Kopan R,. SnapShot: notch signaling pathway. Cell 2007; 128: 1246.
5. Shi S, Stanley P,. Protein O-fucosyltransferase 1 is an essential component of Notch signaling pathways. Proc Natl Acad Sci U S A 2003; 100: 5234-5239. (Pubitemid 36542688)
6. Chen J, Moloney DJ, Stanley P,. Fringe modulation of Jagged1-induced Notch signaling requires the action of beta 4galactosyltransferase-1. Proc Natl Acad Sci U S A 2001; 98: 13716-13721. (Pubitemid 33115964)
7. Ray WJ, Yao M, Mumm J, et al., Cell surface presenilin-1 participates in the gamma-secretase-like proteolysis of Notch. J Biol Chem 1999; 274: 36801-36807.
8. De Strooper B, Annaert W, Cupers P, et al., A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 1999; 398: 518-522.
9. Mumm JS, Schroeter EH, Saxena MT, et al., A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol Cell 2000; 5: 197-206. (Pubitemid 30628079)
10. Jarriault S, Brou C, Logeat F, et al., Signalling downstream of activated mammalian Notch. Nature 1995; 377: 355-358.
11. Qi R, An H, Yu Y, et al., Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res 2003; 63: 8323-8329. (Pubitemid 37549485)
12. Yang X, Klein R, Tian X, et al., Notch activation induces apoptosis in neural progenitor cells through a p53-dependent pathway. Dev Biol 2004; 269: 81-94. (Pubitemid 38471825)
13. Ciofani M, Zuniga-Pflucker JC,. Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism. Nature Immunol 2005; 6: 881-888. (Pubitemid 43090442)
14. Shin HM, Minter LM, Cho OH, et al., Notch1 augments NF-kappaB activity by facilitating its nuclear retention. EMBO J 2006; 25: 129-138. (Pubitemid 43077302)
15. Cheng HT, Kim M, Valerius MT, et al., Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development 2007; 134: 801-811. (Pubitemid 46437921)
16. Morrow D, Guha S, Sweeney C, et al., Notch and vascular smooth muscle cell phenotype. Circ Res 2008; 103: 1370-1382.
17. Tien AC, Rajan A, Bellen HJ,. A Notch updated. J Cell Biol 2009; 184: 621-629.
18. Steidl C, Leimeister C, Klamt B, et al., Characterization of the human and mouse HEY1, HEY2, and HEYL genes: cloning, mapping, and mutation screening of a new bHLH gene family. Genomics 2000; 66: 195-203. (Pubitemid 30429754)
19. Leimeister C, Bach A, Woolf AS, et al., Screen for genes regulated during early kidney morphogenesis. Dev Genet 1999; 24: 273-283. (Pubitemid 29211791)
20. Bielesz B, Sirin Y, Si H, et al., Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest 2010; 120: 4040-4054.
21. Callahan R, Egan SE,. Notch signaling in mammary development and oncogenesis. J Mammary Gland Biol Neoplasia 2004; 9: 145-163. (Pubitemid 39177500)
22. Koo BK, Yoon KJ, Yoo KW, et al., Mind bomb-2 is an E3 ligase for Notch ligand. J Biol Chem 2005; 280: 22335-22342.
23. Koo BK, Yoon MJ, Yoon KJ, et al., An obligatory role of mind bomb-1 in notch signaling of mammalian development. PLoS One 2007; 2: e1221.
24. Ranganathan P, Weaver KL, Capobianco AJ,. Notch signalling in solid tumours: a little bit of everything but not all the time. Nature Rev Cancer 2011; 11: 338-351.
25. Fortini ME,. Notch signaling: the core pathway and its posttranslational regulation. Dev Cell 2009; 16: 633-647.
26. Kim J, Sebring A, Esch JJ, et al., Integration of positional signals and regulation of wing formation and identity by Drosophila vestigial gene. Nature 1996; 382: 133-138. (Pubitemid 26242872)
27. Lai EC,. Notch signaling: control of cell communication and cell fate. Development 2004; 131: 965-973. (Pubitemid 38380451)
28. Kopan R, Turner DL,. The Notch pathway: democracy and aristocracy in the selection of cell fate. Curr Opin Neurobiol 1996; 6: 594-601. (Pubitemid 26387712)
29. Nye JS, Kopan R, Axel R,. An activated Notch suppresses neurogenesis and myogenesis but not gliogenesis in mammalian cells. Development 1994; 120: 2421-2430. (Pubitemid 24268817)
30. Kopan R, Nye JS, Weintraub H,. The intracellular domain of mouse Notch: a constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD. Development 1994; 120: 2385-2396. (Pubitemid 24268814)
31. Oda T, Elkahloun AG, Pike BL, et al., Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nature Genet 1997; 16: 235-242.
32. Li L, Krantz ID, Deng Y, et al., Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nature Genet 1997; 16: 243-251.
33. Habib R, Dommergues JP, Gubler MC, et al., Glomerular mesangiolipidosis in Alagille syndrome (arteriohepatic dysplasia). Pediatr Nephrol 1987; 1: 455-464. (Pubitemid 18016646)
34. Alagille D, Estrada A, Hadchouel M, et al., Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases. J Pediatr 1987; 110: 195-200. (Pubitemid 17016845)
35. Alagille D, Odievre M, Gautier M, et al., Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur. J Pediatr 1975; 86: 63-71.
36. Nyfeler Y, Kirch RD, Mantei N, et al., Jagged1 signals in the postnatal subventricular zone are required for neural stem cell self-renewal. EMBO J 2005; 24: 3504-3515. (Pubitemid 41486787)
37. Schedl A,. Renal abnormalities and their developmental origin. Nature Rev 2007; 8: 791-802. (Pubitemid 47429212)
38. Costantini F, Kopan R,. Patterning a complex organ: branching morphogenesis and nephron segmentation in kidney development. Dev Cell 2010; 18: 698-712.
39. Davies JA,. Morphogenesis of the metanephric kidney. Sci World J 2002; 2: 1937-1950.
40. Durbec P, Marcos-Gutierrez CV, Kilkenny C, et al., GDNF signalling through the Ret receptor tyrosine kinase. Nature 1996; 381: 789-793. (Pubitemid 26243119)
41. Vega QC, Worby CA, Lechner MS, et al., Glial cell line-derived neurotrophic factor activates the receptor tyrosine kinase RET and promotes kidney morphogenesis. Proc Natl Acad Sci U S A 1996; 93: 10657-10661. (Pubitemid 26333044)
42. Moore MW, Klein RD, Farinas I, et al., Renal and neuronal abnormalities in mice lacking GDNF. Nature 1996; 382: 76-79. (Pubitemid 26243361)
43. Pichel JG, Shen L, Sheng HZ, et al., Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 1996; 382: 73-76.
44. Sanchez MP, Silos-Santiago I, Frisen J, et al., Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 1996; 382: 70-73. (Pubitemid 26243359)
45. Carroll TJ, Park JS, Hayashi S, et al., Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev Cell 2005; 9: 283-292. (Pubitemid 41051746)
46. Stark K, Vainio S, Vassileva G, et al., Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 1994; 372: 679-683.
47. Majumdar A, Vainio S, Kispert A, et al., Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric branching during metanephric kidney development. Development 2003; 130: 3175-3185. (Pubitemid 36926955)
48. Chen L, Al-Awqati Q,. Segmental expression of Notch and Hairy genes in nephrogenesis. Am J Physiol 2005; 288: F939-952. (Pubitemid 40569760)
49. Piscione TD, Wu MY, Quaggin SE,. Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis. Gene Expr Patterns 2004; 4: 707-711. (Pubitemid 39307534)
50. McCright B,. Notch signaling in kidney development. Curr Opin Nephrol Hypertens 2003; 12: 5-10. (Pubitemid 36092308)
51. Hellstrom M, Phng LK, Hofmann JJ, et al., Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 2007; 445: 776-780. (Pubitemid 46279716)
52. McCright B, Lozier J, Gridley T,. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 2002; 129: 1075-1082. (Pubitemid 34874130)
53. Wang P, Pereira FA, Beasley D, et al., Presenilins are required for the formation of comma- and S-shaped bodies during nephrogenesis. Development 2003; 130: 5019-5029. (Pubitemid 37321883)
54. Cheng HT, Kopan R,. The role of Notch signaling in specification of podocyte and proximal tubules within the developing mouse kidney. Kidney Int 2005; 68: 1951-1952. (Pubitemid 43117769)
55. Cheng HT, Miner JH, Lin M, et al., Gamma-secretase activity is dispensable for mesenchyme-to-epithelium transition but required for podocyte and proximal tubule formation in developing mouse kidney. Development 2003; 130: 5031-5042. (Pubitemid 37321884)
56. McCright B, Gao X, Shen L, et al., Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. Development 2001; 128: 491-502. (Pubitemid 32229592)
57. Surendran K, Boyle S, Barak H, et al., The contribution of Notch1 to nephron segmentation in the developing kidney is revealed in a sensitized Notch2 background and can be augmented by reducing Mint dosage. Dev Biol 2010; 337: 386-395.
58. Bonegio RG, Beck LH, Kahlon RK, et al., The fate of Notch-deficient nephrogenic progenitor cells during metanephric kidney development. Kidney Int 2010; 79: 1099-1112.
59. Fujimura S, Jiang Q, Kobayashi C, et al., Notch2 activation in the embryonic kidney depletes nephron progenitors. J Am Soc Nephrol 2010; 21: 803-810.
60. Nishinakamura R, Uchiyama Y, Sakaguchi M, et al., Nephron progenitors in the metanephric mesenchyme. Pediatr Nephrol 2011; 26: 1463-1467.
61. Madsen KM, Tisher CC,. Structural-functional relationship along the distal nephron. Am J Physiol 1986; 250: F1-15.
62. Nielsen S, Kwon TH, Christensen BM, et al., Physiology and pathophysiology of renal aquaporins. J Am Soc Nephrol 1999; 10: 647-663. (Pubitemid 29117647)
63. Jeong HW, Jeon US, Koo BK, et al., Inactivation of Notch signaling in the renal collecting duct causes nephrogenic diabetes insipidus in mice. J Clin Invest 2009; 119: 3290-3300.
64. Liu Y, Pathak N, Kramer-Zucker A, et al., Notch signaling controls the differentiation of transporting epithelia and multiciliated cells in the zebrafish pronephros. Development 2007; 134: 1111-1122. (Pubitemid 46630079)
65. Ma M, Jiang YJ,. Jagged2a-notch signaling mediates cell fate choice in the zebrafish pronephric duct. PLoS Genet 2007; 3: e18.
66. Surendran K, Selassie M, Liapis H, et al., Reduced Notch signaling leads to renal cysts and papillary microadenomas. J Am Soc Nephrol 2010; 21: 819-832.
67. Niranjan T, Bielesz B, Gruenwald A, et al., The Notch pathway in podocytes plays a role in the development of glomerular disease. Nature Med 2008; 14: 290-298. (Pubitemid 351347919)
68. Lazzeri E, Mazzinghi B, Romagnani P,. Regeneration and the kidney. Curr Opin Nephrol Hypertens 2010; 19: 248-253.
69. Venkatachalam MA, Griffin KA, Lan R, et al., Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol 2010; 298: F1078-F1094.
70. Kobayashi T, Terada Y, Kuwana H, et al., Expression and function of the Delta-1/Notch-2/Hes-1 pathway during experimental acute kidney injury. Kidney Int 2008; 73: 1240-1250. (Pubitemid 351693161)
71. Gupta S, Li S, Abedin MJ, et al., Effect of Notch activation on the regenerative response to acute renal failure. Am J Physiol 2010; 298: F209-F215.
72. Morrissey J, Guo G, Moridaira K, et al., Transforming growth factor-beta induces renal epithelial jagged-1 expression in fibrotic disease. J Am Soc Nephrol 2002; 13: 1499-1508. (Pubitemid 34579239)
73. Murea M, Park JK, Sharma S, et al., Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function. Kidney Int 2010; 78: 514-522.
74. Niranjan T, Murea M, Susztak K,. The pathogenic role of notch activation in podocytes. Nephron 2009; 111: e73-e79.
75. Zavadil J, Cermak L, Soto-Nieves N, et al., Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 2004; 23: 1155-1165. (Pubitemid 38436879)
76. Niimi H, Pardali K, Vanlandewijck M, et al., Notch signaling is necessary for epithelial growth arrest by TGF-beta. J Cell Biol 2007; 176: 695-707. (Pubitemid 46333983)
77. Dees C, Tomcik M, Zerr P, et al., Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis. Ann Rheum Dis 2011; 70: 1304-1310.
78. Dees C, Zerr P, Tomcik M, et al., Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis. Arthr Rheum 2011; 63: 1396-1404.
79. Zhu F, Li T, Qiu F, et al., Preventive effect of Notch signaling inhibition by a gamma-secretase inhibitor on peritoneal dialysis fluid-induced peritoneal fibrosis in rats. Am J Pathol 2010; 176: 650-659.
80. Sharma M, Callen S, Zhang D, et al., Activation of Notch signaling pathway in HIV-associated nephropathy. AIDS 2011; 24: 2161-2170.
81. Walsh DW, Roxburgh SA, McGettigan P, et al., Co-regulation of Gremlin and Notch signalling in diabetic nephropathy. Biochim Biophys Acta 2008; 1782: 10-21.
82. Lasagni L, Ballerini L, Angelotti ML, et al., Notch activation regulates differentially renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders. Stem Cells 2010; 28: 1674-1685.
83. Yoon K, Gaiano N,. Notch signaling in the mammalian central nervous system: insights from mouse mutants. Nature Neurosci 2005; 8: 709-715. (Pubitemid 43085834)
84. Pierfelice T, Alberi L, Gaiano N,. Notch in the vertebrate nervous system: an old dog with new tricks. Neuron 2011; 69: 840-855.
85. Ahn SH, Susztak K,. Getting a notch closer to understanding diabetic kidney disease. Diabetes 2010; 59: 1865-1867.
86. Lin CL, Wang FS, Hsu YC, et al., Modulation of notch-1 signaling alleviates vascular endothelial growth factor-mediated diabetic nephropathy. Diabetes 2010; 59: 1915-1925.
87. Teachey DT, Seif AE, Brown VI, et al., Targeting Notch signaling in autoimmune and lymphoproliferative disease. Blood 2008; 111: 705-714.
88. Peruzzi B, Athauda G, Bottaro DP,. The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells. Proc Natl Acad Sci U S A 2006; 103: 14531-14536. (Pubitemid 44484784)
89. Turcotte S, Chan DA, Sutphin PD, et al., A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell 2008; 14: 90-102. (Pubitemid 351885499)
90. Gustafsson MV, Zheng X, Pereira T, et al., Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 2005; 9: 617-628. (Pubitemid 41555144)
91. Karbowniczek M, Zitserman D, Khabibullin D, et al., The evolutionarily conserved TSC/Rheb pathway activates Notch in tuberous sclerosis complex and Drosophila external sensory organ development. J Clin Invest 2010; 120: 93-102.
92. Patel U, Simpson E, Kingswood JC, et al., Tuberose sclerosis complex: analysis of growth rates aids differentiation of renal cell carcinoma from atypical or minimal-fat-containing angiomyolipoma. Clin Radiol 2005; 60: 665-673; discussion 663-664. (Pubitemid 40984061)
93. Aparicio LM, Villaamil VM, Gallego GA, et al., Expression of Notch1 to -4 and their ligands in renal cell carcinoma: a tissue microarray study. Cancer Genom Proteom 2011; 8: 93-101.
94. Rae FK, Stephenson SA, Nicol DL, et al., Novel association of a diverse range of genes with renal cell carcinoma as identified by differential display. Int J Cancer 2000; 88: 726-732.
95. Sun S, Du R, Gao J, et al., Expression and clinical significance of Notch receptors in human renal cell carcinoma. Pathology 2009; 41: 335-341.
96. Patard JJ, Leray E, Rioux-Leclercq N, et al., Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 2005; 23: 2763-2771. (Pubitemid 46179466)
97. Sjolund J, Johansson M, Manna S, et al., Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo. J Clin Invest 2008; 118: 217-228.
98. Liang L, Zhang HW, Liang J, et al., KyoT3, an isoform of murine FHL1, associates with the transcription factor RBP-J and represses the RBP-J-mediated transactivation. Biochim Biophys Acta 2008; 1779: 805-810.
99. Weng AP, Ferrando AA, Lee W, et al., Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269-271. (Pubitemid 39336870)
100. Ridgway J, Zhang G, Wu Y, et al., Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 2006; 444: 1083-1087. (Pubitemid 46018529)
101. Wolfe MS,. Therapeutic strategies for Alzheimer's disease. Nature Rev Drug Discov 2002; 1: 859-866. (Pubitemid 37361581)
102. Wolfe MS, Esler WP, Das C,. Continuing strategies for inhibiting Alzheimer's gamma-secretase. J Mol Neurosci 2002; 19: 83-87. (Pubitemid 35013338)
103. Tsai JY, Wolfe MS, Xia W,. The search for gamma-secretase and development of inhibitors. Curr Med Chem 2002; 9: 1087-1106.
104. van Es JH, van Gijn ME, Riccio O, et al., Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005; 435: 959-963. (Pubitemid 40896322)
105. Wu Y, Cain-Hom C, Choy L, et al., Therapeutic antibody targeting of individual Notch receptors. Nature 2010; 464: 1052-1057.
106. Real PJ, Tosello V, Palomero T, et al., Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nature Med 2009; 15: 50-58.